FDA Oncology Center of Excellence landscape analysis of real-world data submissions for oncology drugs.

被引：0
|
作者：
Rivera, Donna [1 ]
Lee, Jennifer J. [1 ]
Royce, Melanie E. [1 ]
Kluetz, Paul Gustav [1 ]
机构：
[1] US FDA, Silver Spring, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e18787
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18787
引用
收藏
页数：3
相关论文
共 50 条
  • [21] AN ONCOLOGY REAL-WORLD DATA ASSESSMENT FRAMEWORK FOR OUTCOMES RESEARCH
    Desai, K.
    Chandwani, S.
    Ru, B.
    Reynolds, M.
    Christian, J. B.
    Estiri, H.
    VALUE IN HEALTH, 2021, 24 : S25 - S25
  • [22] Analysis of genomic alterations and treatment landscape in patients with advanced tumors using real-world data for precision oncology.
    Karagoz, Kubra
    Ayers, Kristin
    Patel, Bonny
    Wells, Jason D.
    Newman, Scott
    Oh, William K.
    Zhou, Xiang
    Chen, Rong
    Guin, Sunny
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [23] The FDA Oncology Center of Excellence Scientific Collaborative: Charting a Course for Applied Regulatory Science Research in Oncology
    Schneider, Julie A.
    Gong, Yutao
    Goldberg, Kirsten B.
    Kluetz, Paul G.
    Theoret, Marc R.
    Amiri-Kordestani, Laleh
    Beaver, Julia A.
    Fashoyin-Aje, Lola
    Gormley, Nicole J.
    Jaigirdar, Adnan A.
    Lemery, Steven J.
    Mishra-Kalyani, Pallavi S.
    Reaman, Gregory H.
    Rivera, Donna R.
    Rubinstein, Wendy S.
    Singh, Harpreet
    Sridhara, Rajeshwari
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2021, 27 (19) : 5161 - 5167
  • [24] An analysis of FDA-approved drugs for oncology
    Kinch, Michael S.
    DRUG DISCOVERY TODAY, 2014, 19 (12) : 1831 - 1835
  • [25] ASSESSING THE QUALITY OF REAL-WORLD DATA AND REAL-WORLD EVIDENCE IN ONCOLOGY RESEARCH: A COHESIVE FRAMEWORK FOR RESEARCHERS
    Su, Z.
    Dye, J.
    Wilson, T.
    Amirian, E. S.
    O'Sullivan, A.
    VALUE IN HEALTH, 2023, 26 (06) : S377 - S377
  • [26] NSCLC: Real-world data analysis from a chain of oncology centres in Western India
    Shivchhand, A. A.
    Joshi, A.
    Maheshwari, U.
    Maniar, V.
    Joshi, K.
    Kalaskar, P.
    Sheth, S.
    Kendre, P.
    Korgavkar, R.
    Morzaria, D.
    Pethe, C.
    Dhande, S.
    Mekha, M.
    Rane, D.
    Jagiasi, S.
    ANNALS OF ONCOLOGY, 2022, 33 : S16 - S16
  • [27] A descriptive analysis of real-world oncology biosimilar use in Japan
    Roth, Joshua A.
    Rahshenas, Makan
    Nowacki, Gregoire
    Masurkar, Nihar
    Shelbaya, Ahmed
    Tajima, Kentaro
    Dorman, Stephanie
    Ono, Chiho
    FUTURE ONCOLOGY, 2024, 20 (25) : 1837 - 1850
  • [28] IDENTIFICATION AND ASSESSMENT OF REAL-WORLD ONCOLOGY DATA IN CHINA: A DATA LANDSCAPING STUDY
    Ban, L.
    Li, J.
    Pulfer, A.
    VALUE IN HEALTH, 2023, 26 (12) : S513 - S513
  • [29] USING REAL-WORLD CLAIMS DATA FOR PLANNING ONCOLOGY CLINICAL TRIALS
    Foley, K. A.
    Hansen, L. G.
    VALUE IN HEALTH, 2013, 16 (03) : A51 - A51
  • [30] Racial and ethnic disparities in a real-world precision oncology data registry
    Cheung, Alexander T. M.
    Palapattu, Elina L. L.
    Pompa, Isabella R. R.
    Aldrighetti, Christopher M. M.
    Niemierko, Andrzej
    Willers, Henning
    Huang, Franklin
    Vapiwala, Neha
    Van Allen, Eliezer
    Kamran, Sophia C. C.
    NPJ PRECISION ONCOLOGY, 2023, 7 (01)
12345